These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37149627)

  • 1. Pachychoroid neovasculopathy has clinical properties that differ from conventional neovascular age-related macular degeneration.
    Kuranami A; Maruko R; Maruko I; Hasegawa T; Iida T
    Sci Rep; 2023 May; 13(1):7379. PubMed ID: 37149627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration.
    Matsumoto H; Hiroe T; Morimoto M; Mimura K; Ito A; Akiyama H
    Jpn J Ophthalmol; 2018 Mar; 62(2):144-150. PubMed ID: 29411171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative and quantitative comparisons of type 1 macular neovascularizations between pachychoroid neovasculopathy and neovascular age-related macular degeneration using optical coherence tomography angiography.
    Yanık Ö; Demirel S; Özcan G; Batıoğlu F; Özmert E
    Eye (Lond); 2024 Jun; 38(9):1714-1721. PubMed ID: 38472377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of Pachychoroid Neovasculopathy into Aneurysmal Type 1 Choroidal Neovascularization or Polypoidal Choroidal Vasculopathy.
    Siedlecki J; Klaas JE; Keidel LF; Asani B; Luft N; Priglinger SG; Schworm B
    Ophthalmol Retina; 2022 Sep; 6(9):807-813. PubMed ID: 35398547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pachychoroid neovasculopathy versus macular neovascularization in age-related macular degeneration with and without shallow irregular pigment epithelial detachment.
    Riazi-Esfahani H; Asadi Khameneh E; Ghassemi F; Mehrabi Bahar M; Torkashvand A; Mahmoudi A; Husein Ahmed A; Faghihi S; Rahimi M; Akbarzadeh A; Faghihi H; Khalili Pour E
    Sci Rep; 2023 Nov; 13(1):19513. PubMed ID: 37945766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features of neovascularization in pachychoroid neovasculopathy compared with type 1 neovascular age-related macular degeneration on optical coherence tomography angiography.
    Arf S; Sayman Muslubas I; Hocaoglu M; Ersoz MG; Karacorlu M
    Jpn J Ophthalmol; 2020 May; 64(3):257-264. PubMed ID: 32157483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanishing pachy-choroid in pachychoroid neovasculopathy under long-term anti-vascular endothelial growth factor therapy.
    Schworm B; Luft N; Keidel LF; Kreutzer TC; Herold TR; Priglinger SG; Siedlecki J
    BMC Ophthalmol; 2021 Jun; 21(1):269. PubMed ID: 34193089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of type 1 neovascularization: Neovascular age-related macular degeneration versus pachychoroid neovasculopathy.
    Altinisik M; Kurt E; Sonmezer P; Kayikcioglu O; Ilker SS
    Eur J Ophthalmol; 2022 Jul; 32(4):2404-2411. PubMed ID: 34374308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pachychoroid neovasculopathy: a type-1 choroidal neovascularization belonging to the pachychoroid spectrum-pathogenesis, imaging and available treatment options.
    Sartini F; Figus M; Casini G; Nardi M; Posarelli C
    Int Ophthalmol; 2020 Dec; 40(12):3577-3589. PubMed ID: 32729062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vortex Vein Anastomosis at the Watershed in Pachychoroid Spectrum Diseases.
    Matsumoto H; Hoshino J; Mukai R; Nakamura K; Kikuchi Y; Kishi S; Akiyama H
    Ophthalmol Retina; 2020 Sep; 4(9):938-945. PubMed ID: 32651158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilated choroidal vascular channels in pachychoroid neovasculopathy.
    Hung JH; Yang CM; Yang CH; Ho TC; Lai TT; Hsieh YT
    Clin Exp Ophthalmol; 2023 Jan; 51(1):44-57. PubMed ID: 36258650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of choroidal structure and its response to anti-VEGF treatment with the short-time outcome in pachychoroid neovasculopathy.
    Azuma K; Tan X; Asano S; Shimizu K; Ogawa A; Inoue T; Murata H; Asaoka R; Obata R
    PLoS One; 2019; 14(2):e0212055. PubMed ID: 30763369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular Vascular Endothelial Growth Factor Levels in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.
    Hata M; Yamashiro K; Ooto S; Oishi A; Tamura H; Miyata M; Ueda-Arakawa N; Takahashi A; Tsujikawa A; Yoshimura N
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):292-298. PubMed ID: 28114590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pachychoroid neovasculopathy: aspect on optical coherence tomography angiography.
    Azar G; Wolff B; Mauget-Faÿsse M; Rispoli M; Savastano MC; Lumbroso B
    Acta Ophthalmol; 2017 Jun; 95(4):421-427. PubMed ID: 27597633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using optical coherence tomography angiography in assessment of the anti-vascular endothelial growth factor effect for pathological vascular tissue in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Shen YS; Cheng CK
    Eur J Ophthalmol; 2021 May; 31(3):1267-1280. PubMed ID: 32228025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Regional Differences in the Choroidal Thickness between Patients with Pachychoroid Neovasculopathy and Classic Exudative Age-related Macular Degeneration.
    Kim YH; Lee B; Kang E; Oh J
    Curr Eye Res; 2021 Sep; 46(9):1398-1405. PubMed ID: 33550884
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2.
    Chong Teo KY; Sadda SR; Gemmy Cheung CM; Chakravarthy U; Staurenghi G; Invernizzi A; Ogura Y; Ruamviboonsuk P; Chen SJ; Gupta V; Tan C; Chhablani J; Corvi F; Kim JE; Gomi F; Koh AH; Kokame G; Mitchell P; Wong TY; Lee WK; Lai TYY
    Ophthalmol Retina; 2021 Oct; 5(10):945-953. PubMed ID: 33866022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy.
    Yoon J; Yoon W; Na SK; Lee J; Kim CG; Kim JW; Cho HJ
    Sci Rep; 2021 Jun; 11(1):12052. PubMed ID: 34103603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and pachychoroid incidence in Japanese patients with neovascular age-related macular degeneration.
    Matsumoto H; Hoshino J; Mukai R; Nakamura K; Kishi S; Akiyama H
    Sci Rep; 2022 Mar; 12(1):4492. PubMed ID: 35296769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASSOCIATION OF TREATMENT RESPONSE WITH QUANTITATIVE CHANGES IN CHOROIDAL NEOVASCULARIZATION AND CHOROIDAL VESSEL IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Lee H; Lee M; Kim MA; Chung H; Kim HC
    Retina; 2020 Sep; 40(9):1704-1718. PubMed ID: 31725526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.